Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement

NCT06818630 is registered in ClinicalTrials.gov with L'Oréal Taiwan Co., Ltd as lead sponsor.

NCT NCT06818630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06818630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement
Lead sponsor
L'Oréal Taiwan Co., Ltd
Phase
Not applicable
Overall status
Completed
Start date
July 29, 2024
Completion date
January 23, 2025
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin quality improvement